The Interplay Between miRNA and Mitochondrial Dysfunction in Neurodegenerative Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 281
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to present a new Special Issue entitled “The Interplay Between miRNA and Mitochondrial Dysfunction in Neurodegenerative Diseases”.
MicroRNAs (miRNAs) are small non-coding RNAs that play a pivotal role in post-transcriptional gene regulation. They are involved in nearly every aspect of fundamental physiological and pathological cellular functions. Over the past decade, our understanding of miRNA biology, their target genes, biomarkers, and potential therapeutic applications has significantly increased. The role of nuclear DNA-encoded miRNAs in the progression of various neurological diseases, such as Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease, is well established.
However, our knowledge about mitochondrial miRNAs remains limited. These miRNAs either originate from the mitochondrial genome or are directly translocated into the mitochondria. In this context, emerging evidence suggests a potential interplay between mitochondrial dysfunction and miRNA in the progression of various neurodegenerative diseases.
This Special Issue welcomes contributions that expand our understanding of gene expression regulation by either nuclear DNA-encoded microRNAs and/or mitochondrial miRNAs in neurodegenerative diseases, and the involvement of mitochondrial dysfunctions in these pathologies.
We look forward to receiving submissions from outstanding experts in the field.
Dr. Mariano Catanesi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- miRNA
- neurodegenerative diseases
- mitochondrial dysfunction
- aging
- gene expression
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
